AcuSurgical, a Montpellier, France-based-based company focused on robotic microsurgery, raised €5.75m in Series A financing. The company intends to use the funds to conduct clinical trials and reach regulatory approval with vitreo-retinal surgery as the first indication. Founded by Christoph Spuhler, serving as Chief Executive Officer, AcuSurgical uses advanced robotics to make ocular microsurgery safe and accessible by improving the precision of surgical interventions. A proof of concept of the platform has already been completed with a first prototype validated in a preclinical setting. The robotic platform aims to increase the precision of current procedures, filtering tremor and augmenting visualization with the aid of a telemanipulated robot, while the surgeon remains in complete control.